Increased Exosomal MicroRNA-21 and MicroRNA-146a Levels in the Cervicovaginal Lavage Specimens of Patients with Cervical Cancer

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2014 Jan 11

PMID 24406730

Citations 81

Authors

Jie Liu

Hong Sun

Xiaoli Wang

Qun Yu

Shuhong Li

Xiaoyan Yu

Wenwen Gong

Affiliations

Soon will be listed here.

Abstract

Well-run screening programs for cervical cancer in the population at risk have been shown to result in a sharp decrease in the incidence and mortality of cervical cancer in a number of large populations. Expression patterns of a recently identified biomarker family, microRNA, appear to be characteristic of tumor type and developmental origin. Several tumors have been reported to actively release exosomes carrying microRNAs. The present study has determined the association of microRNAs with cervical cancer-derived exosomes. The cervical cancer-derived exosomes were enriched in the cervicovaginal lavages specimens and the abundance of exosomes and exosomal microRNAs was detected by electron microscopy, western blot analysis, RT-qPCR and microRNA target reporter vector. The microRNA-21 and microRNA-146a, which were up-regulated in cervical cancer patients, were associated with the high levels of cervical cancer-derived exosomes. In conclusion, we demonstrated the abundance of exosomes in the cervicovaginal lavage specimens of women with cervical cancer. Furthermore, our results indicated that abnormally high levels of microRNA-21 and microRNA-146a existed in the cervical cancer-derived exosomes and the two microRNAs were functional in 293T cells.

Citing Articles

MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring.

Kepsha M, Timofeeva A, Chernyshev V, Silachev D, Mezhevitinova E, Sukhikh G Int J Mol Sci. 2025; 25(24.

PMID: 39769036 PMC: 11678179. DOI: 10.3390/ijms252413271.

Biological functions of extracellular vesicle double C2-like domain beta in cervical cancer.

Eswaran S, Bhat S, Upadhya D, Mascarenhas R, Kabekkodu S Sci Rep. 2025; 15(1):477.

PMID: 39747389 PMC: 11695970. DOI: 10.1038/s41598-024-84643-2.

A State-of-the-Art Review on the Recent Advances in Exosomes in Oncogenic Virus.

Ebrahimi F, Modaresi Movahedi A, Sabbaghian M, Poortahmasebi V Health Sci Rep. 2024; 7(11):e70196.

PMID: 39558933 PMC: 11570872. DOI: 10.1002/hsr2.70196.

The role of extracellular vesicles in the pathogenesis of gynecological cancer.

Chatterjee M, Gupta S, Mukherjee T, Parashar D, Kumar U, Maitra A Front Oncol. 2024; 14:1477610.

PMID: 39391238 PMC: 11464257. DOI: 10.3389/fonc.2024.1477610.

Enhancing outcome prediction of concurrent chemoradiation treatment in patients with locally advanced cervical cancer through plasma extracellular vesicle proteomics.

Leetanaporn K, Chiangjong W, Roytrakul S, Molika P, Janmunee N, Atjimakul T Heliyon. 2024; 10(16):e36374.

PMID: 39262965 PMC: 11388600. DOI: 10.1016/j.heliyon.2024.e36374.

References

Yao Q, Xu H, Zhang Q, Zhou H, Qu L . MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun. 2009; 388(3):539-42. DOI: 10.1016/j.bbrc.2009.08.044. View

Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodhill A . Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007; 370(9599):1609-21. DOI: 10.1016/S0140-6736(07)61684-5. View

Aharon A, Tamari T, Brenner B . Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost. 2008; 100(5):878-85. DOI: 10.1160/th07-11-0691. View

Cai N, Wang Y, Zheng P . The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1. RNA. 2012; 19(1):85-95. PMC: 3527729. DOI: 10.1261/rna.035295.112. View

de Sanjose S, Quint W, Alemany L, Geraets D, Klaustermeier J, Lloveras B . Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-8. View

Jemal A, Center M, DeSantis C, Ward E . Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010; 19(8):1893-907. DOI: 10.1158/1055-9965.EPI-10-0437. View

Munoz N, Bosch F, de Sanjose S, Herrero R, Castellsague X, Shah K . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6):518-27. DOI: 10.1056/NEJMoa021641. View

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

Tian R, Wang X, Hou L, Jia W, Yang Q, Li Y . MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. J Biol Chem. 2011; 286(29):25556-63. PMC: 3138314. DOI: 10.1074/jbc.M111.221564. View

10.

Rabinowits G, Gercel-Taylor C, Day J, Taylor D, Kloecker G . Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10(1):42-6. DOI: 10.3816/CLC.2009.n.006. View

11.

Deftereos G, Corrie S, Feng Q, Morihara J, Stern J, Hawes S . Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One. 2011; 6(12):e28423. PMC: 3237431. DOI: 10.1371/journal.pone.0028423. View

12.

Denzer K, Kleijmeer M, Heijnen H, Stoorvogel W, Geuze H . Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci. 2000; 113 Pt 19:3365-74. DOI: 10.1242/jcs.113.19.3365. View

13.

Gallo A, Tandon M, Alevizos I, Illei G . The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012; 7(3):e30679. PMC: 3302865. DOI: 10.1371/journal.pone.0030679. View

14.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

15.

Sigurdsson K . Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991. Int J Cancer. 1993; 54(4):563-70. DOI: 10.1002/ijc.2910540408. View

16.

Coutlee F, Hankins C, LaPointe N . Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. The Canadian Women's HIV Study Group. J Med Virol. 1997; 51(1):42-7. DOI: 10.1002/(sici)1096-9071(199701)51:1<42::aid-jmv7>3.0.co;2-s. View

17.

Savina A, Furlan M, Vidal M, Colombo M . Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem. 2003; 278(22):20083-90. DOI: 10.1074/jbc.M301642200. View

18.

Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N . Serum microRNAs are promising novel biomarkers. PLoS One. 2008; 3(9):e3148. PMC: 2519789. DOI: 10.1371/journal.pone.0003148. View

19.

Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J, Rougvie A . The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000; 403(6772):901-6. DOI: 10.1038/35002607. View

20.

Quinn M, Babb P, Jones J, Allen E . Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999; 318(7188):904-8. PMC: 27810. DOI: 10.1136/bmj.318.7188.904. View